Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Sales (2018 - 2025)

Historic Return on Sales for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to 5.19%.

  • Arcus Biosciences' Return on Sales fell 32800.0% to 5.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.42%, marking a year-over-year decrease of 3900.0%. This contributed to the annual value of 1.1% for FY2024, which is 15300.0% up from last year.
  • As of Q3 2025, Arcus Biosciences' Return on Sales stood at 5.19%, which was down 32800.0% from 1.14% recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Return on Sales ranged from a high of 0.79% in Q4 2021 and a low of 8.24% during Q3 2021
  • Moreover, its 5-year median value for Return on Sales was 2.59% (2023), whereas its average is 3.28%.
  • Within the past 5 years, the most significant YoY rise in Arcus Biosciences' Return on Sales was 177300bps (2021), while the steepest drop was -82700bps (2021).
  • Arcus Biosciences' Return on Sales (Quarter) stood at 0.79% in 2021, then crashed by -350bps to 1.97% in 2022, then crashed by -33bps to 2.61% in 2023, then crashed by -38bps to 3.62% in 2024, then tumbled by -44bps to 5.19% in 2025.
  • Its Return on Sales was 5.19% in Q3 2025, compared to 1.14% in Q2 2025 and 4.0% in Q1 2025.